These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 38566909)

  • 21. Bone marrow mesenchymal stem cell-derived exosomes alleviate skin fibrosis in systemic sclerosis by inhibiting the IL-33/ST2 axis via the delivery of microRNA-214.
    Xie L; Long X; Mo M; Jiang J; Zhang Q; Long M; Li M
    Mol Immunol; 2023 May; 157():146-157. PubMed ID: 37028129
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transforming growth factor-β signaling: From tissue fibrosis to therapeutic opportunities.
    Ren LL; Li XJ; Duan TT; Li ZH; Yang JZ; Zhang YM; Zou L; Miao H; Zhao YY
    Chem Biol Interact; 2023 Jan; 369():110289. PubMed ID: 36455676
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The IL-4/IL-13 axis in skin fibrosis and scarring: mechanistic concepts and therapeutic targets.
    Nguyen JK; Austin E; Huang A; Mamalis A; Jagdeo J
    Arch Dermatol Res; 2020 Mar; 312(2):81-92. PubMed ID: 31493000
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effect of hydrocinnamoyl-L-valyl pyrrolidine on healing quality of deep partial-thickness scald wound in mice].
    Yang ML; Li YH; Tan Q; Li JT; Que LL
    Zhonghua Shao Shang Za Zhi; 2016 Nov; 32(11):658-666. PubMed ID: 27894387
    [No Abstract]   [Full Text] [Related]  

  • 25. Rev-erbα agonists suppresses TGFβ1-induced fibroblast-to-myofibroblast transition and pro-fibrotic phenotype in human lung fibroblasts.
    Prasad C; Hahn K; Duraisamy SK; Salathe MA; Huang SK; Burris TP; Sundar IK
    Biochem Biophys Res Commun; 2023 Aug; 669():120-127. PubMed ID: 37269594
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genomics of Human Fibrotic Diseases: Disordered Wound Healing Response.
    Stone RC; Chen V; Burgess J; Pannu S; Tomic-Canic M
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33202590
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Extracellular SPARC cooperates with TGF-β signalling to induce pro-fibrotic activation of systemic sclerosis patient dermal fibroblasts.
    Carvalheiro T; Malvar Fernández B; Ottria A; Giovannone B; Marut W; Reedquist KA; Garcia S; Radstake TR
    Rheumatology (Oxford); 2020 Sep; 59(9):2258-2263. PubMed ID: 31840182
    [TBL] [Abstract][Full Text] [Related]  

  • 28. IL-33/ST2 axis contributes to the dermal fibrosis of systemic sclerosis via promoting fibroblasts activation.
    Wu X; Ming B; Wu T; Gao R; Hu P; Tang J; Zhong J; Zheng F; Dong L
    J Dermatol Sci; 2022 Aug; 107(2):95-104. PubMed ID: 35940987
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interleukin-33/ Suppression of Tumorigenicity 2 in Renal Fibrosis: Emerging Roles in Prognosis and Treatment.
    Tan XY; Jing HY; Ma YR
    Front Physiol; 2021; 12():792897. PubMed ID: 35046838
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Wound healing: an overview of acute, fibrotic and delayed healing.
    Diegelmann RF; Evans MC
    Front Biosci; 2004 Jan; 9():283-9. PubMed ID: 14766366
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatocarcinoma-intestine-pancreas/pancreatitis-associated protein (HIP/PAP) confers protection against hepatic fibrosis through downregulation of transforming growth factor β receptor II.
    Li Q; Li H; Lv Y; Zhang Q; Zhang X; Li S; Zheng X; Wang Y; Hao Z
    Lab Invest; 2020 Mar; 100(3):466-482. PubMed ID: 31641222
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transforming growth factor-beta and Smad signalling in kidney diseases.
    Wang W; Koka V; Lan HY
    Nephrology (Carlton); 2005 Feb; 10(1):48-56. PubMed ID: 15705182
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Th17 cytokines induce pro-fibrotic cytokines release from human eosinophils.
    Al-Muhsen S; Letuve S; Vazquez-Tello A; Pureza MA; Al-Jahdali H; Bahammam AS; Hamid Q; Halwani R
    Respir Res; 2013 Mar; 14(1):34. PubMed ID: 23496774
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanisms of organ fibrosis: Emerging concepts and implications for novel treatment strategies.
    Lurje I; Gaisa NT; Weiskirchen R; Tacke F
    Mol Aspects Med; 2023 Aug; 92():101191. PubMed ID: 37236017
    [TBL] [Abstract][Full Text] [Related]  

  • 35. M2-polarized macrophages mediate wound healing by regulating connective tissue growth factor via AKT, ERK1/2, and STAT3 signaling pathways.
    Zhang SM; Wei CY; Wang Q; Wang L; Lu L; Qi FZ
    Mol Biol Rep; 2021 Sep; 48(9):6443-6456. PubMed ID: 34398425
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New insights into the mechanisms of innate immune receptor signalling in fibrosis.
    Lafyatis R; Farina A
    Open Rheumatol J; 2012; 6():72-9. PubMed ID: 22802904
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cooperation of liver cells in health and disease.
    Kmieć Z
    Adv Anat Embryol Cell Biol; 2001; 161():III-XIII, 1-151. PubMed ID: 11729749
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The involvement of the Wnt/β-catenin signaling cascade in fibrosis progression and its therapeutic targeting by relaxin.
    Somanader DVN; Zhao P; Widdop RE; Samuel CS
    Biochem Pharmacol; 2024 May; 223():116130. PubMed ID: 38490518
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The epithelium in idiopathic pulmonary fibrosis: breaking the barrier.
    Camelo A; Dunmore R; Sleeman MA; Clarke DL
    Front Pharmacol; 2014 Jan; 4():173. PubMed ID: 24454287
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of cytokines and cytokine therapy in wound healing and fibrotic diseases.
    Gharaee-Kermani M; Phan SH
    Curr Pharm Des; 2001 Jul; 7(11):1083-103. PubMed ID: 11472255
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.